These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 1803787

  • 1. Monitoring serum digoxin concentrations during digoxin immune Fab therapy.
    Ujhelyi MR, Colucci RD, Cummings DM, Green PJ, Robert S, Vlasses PH, Zarowitz BJ.
    DICP; 1991 Oct; 25(10):1047-9. PubMed ID: 1803787
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Determination of free digoxin concentrations in serum for monitoring Fab treatment of digoxin overdose.
    Hursting MJ, Raisys VA, Opheim KE, Bell JL, Trobaugh GB, Smith TW.
    Clin Chem; 1987 Sep; 33(9):1652-5. PubMed ID: 3621567
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Review of clinical experience with digoxin immune Fab (ovine).
    Smith TW.
    Am J Emerg Med; 1991 Mar; 9(2 Suppl 1):1-6; discussion 33-4. PubMed ID: 1997014
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Monitoring of unbound digoxin in patients treated with anti-digoxin antigen-binding fragments: a model for the future?
    Valdes R, Jortani SA.
    Clin Chem; 1998 Sep; 44(9):1883-5. PubMed ID: 9732971
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The use of digoxin-specific Fab fragments for severe digitalis intoxication in children.
    Woolf AD, Wenger T, Smith TW, Lovejoy FH.
    N Engl J Med; 1992 Jun 25; 326(26):1739-44. PubMed ID: 1594015
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness analysis of the use of digoxin immune Fab (ovine) for treatment of digoxin toxicity.
    Mauskopf JA, Wenger TL.
    Am J Cardiol; 1991 Dec 15; 68(17):1709-14. PubMed ID: 1746476
    [Abstract] [Full Text] [Related]

  • 18. Digitalis intoxication and treatment with digoxin antibody fragments in renal failure.
    Erdmann E, Mair W, Knedel M, Schaumann W.
    Klin Wochenschr; 1989 Jan 04; 67(1):16-9. PubMed ID: 2921838
    [Abstract] [Full Text] [Related]

  • 19. Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies.
    Smith TW, Haber E, Yeatman L, Butler VP.
    N Engl J Med; 1976 Apr 08; 294(15):797-800. PubMed ID: 943040
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.